- Report
- May 2024
- 192 Pages
Global
From €3219EUR$3,374USD£2,741GBP
€3576EUR$3,749USD£3,046GBP
- Report
- December 2023
- 185 Pages
Global
From €2385EUR$2,500USD£2,031GBP
- Report
- October 2023
- 179 Pages
Global
From €2385EUR$2,500USD£2,031GBP
- Report
- December 2023
- 98 Pages
Global
From €3500EUR$3,930USD£3,085GBP
- Report
- December 2023
- 103 Pages
Global
From €3500EUR$3,930USD£3,085GBP
The Particle Size Reduction market within the Pharmaceuticals industry is a specialized field that focuses on the reduction of particle size of active pharmaceutical ingredients (API) and excipients. This process is used to improve the solubility, bioavailability, and stability of the drug. Particle size reduction is achieved through a variety of methods, such as milling, grinding, and homogenization. The process is also used to improve the flowability of the drug, which is important for the manufacturing process.
Particle size reduction is an important step in the drug development process, as it can affect the efficacy and safety of the drug. It is also used to improve the appearance of the drug, as well as its shelf life.
Some companies in the Particle Size Reduction market within the Pharmaceuticals industry include Quadro Engineering, Hosokawa Micron, and Fitzpatrick. Show Less Read more